Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study)

Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV

(2018) Nikki Mulligan et al.   AIDS

Comparative safety of dolutegravir-based or efavirenz-based antiretroviral treatment started during pregnancy in Botswana: an observational study

(2018) Rebecca Zash et al.   Lancet Global Health

Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception

(2018) Rebecca Zash et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dolutegravir in breast milk and maternal and infant plasma during breastfeeding

(2016) Robin Kobbe et al.   AIDS

The development and application of a novel LC–MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma

(2016) Sujan Dilly Penchala et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Pharmacokinetics of Dolutegravir in a Premature Neonate after HIV Treatment Intensification during Pregnancy

(2015) J. B. Pain et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Plasma viraemia in HIV-positive pregnant women entering antenatal care in South Africa

(2015) Landon Myer et al.   Journal of the International AIDS Society

Early Initiation of ARV During Pregnancy to Move towards Virtual Elimination of Mother-to-Child-Transmission of HIV-1 in Yunnan, China

(2015) Kathrine Meyers et al.   PLoS One

Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir

(2013) Mackenzie L. Cottrell et al.   CLINICAL PHARMACOKINETICS

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

(2013) Sharon L. Walmsley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy

(2012) Kajal Buckoreelall et al.   CLINICAL PHARMACOKINETICS

Antiviral activity, safety, and pharmacokinetics/pharmacodynamics of dolutegravir as 10-day monotherapy in HIV-1-infected adults

(2011) Sherene Min et al.   AIDS

Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool

(2011) Ruairi M. Gallagher et al.   PLoS One

Pharmacokinetics and Safety of S/GSK1349572, a Next-Generation HIV Integrase Inhibitor, in Healthy Volunteers

(2009) S. Min et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY